A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer

NCT05154487 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

51

Enrollment

NETWORK

Sponsor class

Conditions

Endometroid Endometrial Cancer

Interventions

DRUG: Alpelisib Pill
DRUG: Fulvestrant injection

Sponsor

GOG Foundation

Collaborators

[object Object]